BTVNL - ARISTOCORT PARENTERAL & INTRALESIONAL
- MSDS: BTVNL
- Manufacturer: FUJISAWA USA INC (LYPHOMED INC)
- Product Name: ARISTOCORT PARENTERAL & INTRALESIONAL
- National Stock Number: 6505-00F036248
Product Identification
Product ID:ARISTOCORT PARENTERAL & INTRALESIONAL
MSDS Date:01/01/1994
FSC:6505
NIIN:00F036248
MSDS Number: BTVNL
Responsible Party
DEERFIELD, IL 60015-2548
US
Emergency Phone: 708-317-8202/800-727-7003
Info Phone: 708-317-8800
Preparer: CHRISTINA J BARRINGTON
Cage: 24832
Contractor
Telephone: 847-317-1256
Cage: 39832
Ingredients
BENZYL ALCOHOL
CAS: 100-51-6
RTECS: DN3150000
POLYETHYLENE GLYCOL; POLYOXYETHYLENE
CAS: 25322-68-3
RTECS: TQ3500000
POLYSORBATE 80 USP, POLYOXYETHYLENESORBITOL OLEATE, TWEEN
CAS: 9005-65-6
RTECS: WG2932500
SODIUM CHLORIDE
CAS: 7647-14-5
RTECS: VZ4725000
TRIAMCINOLONE DIACETATE
CAS: 67-78-7
RTECS: TU3950000
WATER
CAS: 7732-18-5
RTECS: ZC0110000
Hazards
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:IMMEDIATE EFFECTS: EYE, SKIN & MUCOUS
MEMBRANE IRRITATION MAY OCCUR. DELAYED EFFECTS: PRIMARY IRRITATION
OF SKIN/EYES, FLUID RETENTION, MUSCLE WEAKNESS, IMPAIRED WOUND
HEALING, HEADACHE, VERTIGO & CON VULSIONS HAVE BEEN REPORTED
W/PATIENT ADMINISTRATION.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IMMEDIATE EFFECTS: EYE, SKIN & MUCOUS MEMBRANE
IRRITATION MAY OCCUR. DELAYED EFFECTS: PRIMARY IRRITATION OF
SKIN/EYES, FLUID RETENTION, MUSCLE WEAKNESS, IMPAIRED WOUND
HEALING, HEADACHE, VERTIGO & CON VULSIONS HAVE BEEN REPORTED
W/PATIENT ADMINISTRATION.
Medical Cond Aggravated by Exposure:PRE-EXISTING SKIN CONDITIONS.
First Aid
First Aid:INHALATION: MOVE TO FRESH AIR. GIVE CPR IF REQUIRED.
INGESTION: FLUSH MOUTH OUT W/WATER IMMEDIATELY. SKIN: FLUSH W/WATER
FOR 15 MINS. EYES: IMMEDIATELY FLUSH W/WATER FOR 15 MINS. OBTAIN
MEDICAL ATTENT ION IN ALL CASES.
Fire Fighting
Extinguishing Media:WATER SPRAY, DRY CHEMICAL, CO2/FOAM
Fire Fighting Procedures:WEAR SELF CONTAINED BREATHING APPARATUS &
PROTECTIVE CLOTHING.
Accidental Release
Spill Release Procedures:WEAR RECOMMENDED PERSONAL PROTECTIVE
EQUIPMENT. USE ABSORBENT TOWELS/BOOMS TO CLEAN UP. WIPE SURFACES
CLEAN & WASH W/SOAP & WATER.
Handling
Handling and Storage Precautions:WHEN HANDLING PHARMACEUTICAL PRODUCTS,
AVOID CONTACT & INHALATION OF DUST, FUMES, MIST/VAPORS ASSOCIATED
W/THE PRODUCT.
Exposure Controls
Respiratory Protection:W/SATISFACTORY VENTILATION, NOT USUALLY
REQUIRED.
Ventilation:GENERAL ROOM USUALLY SATISFACTORY; LOCAL EXHAUST WHEN
NECESSARY.
Protective Gloves:DISPOSABLE LATEX
Eye Protection:SAFETY GLASSES/GOGGLES
Other Protective Equipment:DISPOSABLE GARMENTS
Work Hygienic Practices:REMOVE/LAUNDER CONTAMINATED CLOTHING BEFORE
REUSE.
Supplemental Safety and Health
THIS PRODUCT IS INTENDED FOR THERAPEUTIC USE ONLY WHEN PRESCRIBED BY A
PHYSICIAN.
Chemical Properties
pH:6
Appearance and Odor:CLEAR, STERILE SOLUTION.
Stability
Stability Indicator/Materials to Avoid:YES
Stability Condition to Avoid:FREEZING
Hazardous Decomposition Products:SMOKE & FLUORINE FUMES
Disposal
Waste Disposal Methods:DISPOSE OF IN ACCORDANCE W/LOCAL, STATE &
FEDERAL REGULATIONS.
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.